ABCB1 and neoplasm: Efforts to develop molecules which inhibit the function of the drug transporter proteins like P-glycoprotein (Pgp) (encoded by the MDR1 gene) to sensitize tumor cells to anti-cancer agents have met with limited clinical success so far, due to the non-specific nature of these inhibitors (Shukla et al., 2008).